Bio News
Essilor Korea’s myopia-control lens Stellest was found to reduce myopia progression in children by 71% over 2 years. The product received U.S. FDA approval in September last year based on its efficacy compared with single-vision lenses. The company will run a summer vacation campaign and promotion through Sept. 30.
BIOBOOK TEAM
biobookmedia@biobook.co.krKorea National Park Service Uses AI to Identify 17 Wildlife Species, Cuts Analysis Time by 99%
Ipscell Receives Notice of Allowance for Universal iPSC Patent, Strengthening Cell Line Supply Business
Ministry of Trade, Industry and Energy and Ministry of Food and Drug Safety Sign Agreement on AI Transformation and Global Competitiveness in Biotech
Paragon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Korea National Park Service Uses AI to Identify 17 Wildlife Species, Cuts Analysis Time by 99%
Ipscell Receives Notice of Allowance for Universal iPSC Patent, Strengthening Cell Line Supply Business
Ministry of Trade, Industry and Energy and Ministry of Food and Drug Safety Sign Agreement on AI Transformation and Global Competitiveness in Biotech
